US 11975046
Medical use of interferon-lambda for the treatment of fibrosis
granted A61KA61K38/21A61K45/06
Quick answer
US patent 11975046 (Medical use of interferon-lambda for the treatment of fibrosis) held by Five Prime Therapeutics, Inc. expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/21, A61K45/06, A61K47/60, A61P